Is sub-endometrial injection a superior method for the administration of intrauterine PRP?: a systematic review and meta-analysis
Abstract
PURPOSE: Endometrial platelet-rich plasma (PRP) is proposed to treat thin endometrium and implantation failure. Different techniques are described, and nomenclature is often confusing, with infusion or injection being used interchangeably, not discriminating between methods. Sub-endometrial injection, by hysteroscopic or ultrasound guidance, differs from intracavity infusion, but whether this method is superior has not been subject to review. METHODS: A systematic review and meta-analysis was performed to compare sub-endometrial injection against placebo or intra-cavity infusion in a defined assisted reproduction population, with subgroup analysis to assess for any differences between USS-guided or Hysteroscopic Techniques. Primary outcomes were clinical pregnancy (CPR), live birth (LBR), and miscarriage rates (MR). RESULTS: Significant increases in CPR (OR = 5.14, p < 0.001) and LBR (OR = 4.60, p < 0.001) were seen in appropriately selected patients with sub-endometrial PRP injection compared to placebo, with a reduction in MR (OR = 0.60, p = 0.036). The benefit of injection compared to infusion appears highest for CPR in those with a resistant thin endometrium (p = 0.03). CONCLUSIONS: Sub-endometrial administration may improve the efficacy of PRP in selected patients. More work is needed to identify the optimal candidates, and given the additional administration challenges, whether injection should be a first-line intervention, or considered after unsuccessful infusion,…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Drug repositioning: a brief overview
- Cyclic nucleotide phosphodiesterases in Drosophila melanogaster
- Time-resolved in silico modeling of fine-tuned cAMP signaling in platelets: feedback loops, titrated phosphorylations and pharmacological modulation
- Current View on Green Tea Catechins Formulations, Their Interactions with Selected Drugs, and Prospective Applications for Various Health Conditions
- In silico Structure-based Identification of Novel Acetylcholinesterase Inhibitors Against Alzheimer’s Disease
- Development and In Vitro Evaluation of Controlled Release Viagra® Containing Poloxamer-188 Using Gastroplus™ PBPK Modeling Software for In Vivo Predictions and Pharmacokinetic Assessments
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.